Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

University of Exeter Receives Multiple Athena Swan Awards for Gender Equality Commitment

(IN BRIEF) The University of Exeter has received recognition for its dedication to gender equality across various departments in the latest Athena Swan Charter Awards round. Five departments, including Health and Care Professions, University of Exeter Medical School, Ecology and … Read the full press release

EQT Launches Healthcare Growth Strategy and Announces First Investment in Mabtech

(IN BRIEF) EQT has unveiled its EQT Healthcare Growth Strategy and revealed its initial investment in Mabtech, acquired from the IK Small Cap II Fund. The strategy aims to capitalize on long-term healthcare trends, leveraging scientific breakthroughs, technology advancements, and … Read the full press release

Accenture Ventures Invests in QuantHealth to Accelerate AI-Powered Clinical Trial Design

(IN BRIEF) Accenture has announced a strategic investment through Accenture Ventures in QuantHealth, an AI-powered clinical trial design company specializing in cloud-based simulations for pharmaceutical and biotech companies. Using AI technology trained on extensive patient data and clinical trial information, … Read the full press release

Gut Microbiome Composition Linked to Reduced Risk of Graft Versus Host Disease After Stem Cell Transplantation

(IN BRIEF) Researchers from the Technical University of Munich (TUM) and the Universitätsklinikum Regensburg (UKR) have discovered that certain microbes in the gut can significantly reduce the occurrence of graft versus host disease (GvHD) following stem cell transplantation. By analyzing … Read the full press release

Merck KGaA Partners with Inspirna to Advance Novel Therapy for RAS-mutated Colorectal Cancer

(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds, currently under Phase II evaluation for the second-line … Read the full press release

Novo Nordisk Initiates Groundbreaking Collaborations for Innovative Obesity and MASH Treatments

(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches for obesity and MASH (Metabolic Associated Fatty Liver Disease). The collaboration with Omega aims to develop an epigenomic controller to … Read the full press release

Revolutionary AcuPebble Diagnostic Device Aims to Transform Sleep Apnoea Diagnosis

(IN BRIEF) Researchers at the University of Warwick, in collaboration with other institutions and charities, are leading a groundbreaking initiative to improve the diagnosis and treatment of Obstructive Sleep Apnoea (OSA). OSA often goes undiagnosed, leading to sleep disturbances and … Read the full press release

QIAGEN Expands Presence in Middle East with New Riyadh HQ, MoU with Saudi Ministry of Health, and Oman TB Screening Initiative

(IN BRIEF) QIAGEN, a leading provider of molecular diagnostics and life sciences solutions, is significantly expanding its operations in the Middle East region. In early 2024, the company will open its regional headquarters in Riyadh, Saudi Arabia, to strengthen its … Read the full press release

Nordic Investment Bank and Wellbeing Services County Collaborate on €70 Million Hospital Expansion in Finland

(IN BRIEF) The Nordic Investment Bank (NIB) has entered into a 20-year EUR 70 million loan agreement with the Wellbeing Services County (WSC) of North Savo, Finland, to fund the expansion and renovation of the “Uusi Sydän” central hospital and … Read the full press release

AstraZeneca Advances in Cell Therapy with Acquisition of Gracell Biotechnologies

(IN BRIEF) AstraZeneca has announced its definitive agreement to acquire Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company specializing in cell therapies for cancer and autoimmune diseases. This strategic move aims to bolster AstraZeneca’s presence in the field of … Read the full press release

EIB Invests €12.5 Million in Swedish Medical Startup BrainCool AB to Advance Innovative Cooling Technologies

(IN BRIEF) The European Investment Bank (EIB) has signed a €12.5 million venture debt agreement with Swedish medical company BrainCool AB, specializing in medical cooling solutions. BrainCool is pioneering body cooling technologies that have the potential to revolutionize care standards … Read the full press release

Sanofi Ceases Development of Tusamitamab Ravtansine for NSCLC after Trial Misses Primary Endpoint

(IN BRIEF) Sanofi has announced the discontinuation of the global clinical development program for tusamitamab ravtansine, following an interim analysis of the Phase 3 CARMEN-LC03 trial. The trial assessed tusamitamab ravtansine as a monotherapy in previously treated metastatic non-squamous non-small … Read the full press release

Cancer Treatment Advances: FDA Recognizes Breakthrough Potential of BNT323/DB-1303 for Endometrial Cancer

(IN BRIEF) BioNTech and Duality Biologics have received Breakthrough Therapy designation from the FDA for their antibody-drug conjugate (ADC) candidate, BNT323/DB-1303. The designation is for the treatment of advanced endometrial cancer in patients who have progressed following immune checkpoint inhibitor … Read the full press release

Roche’s Xolair Nears FDA Approval for Reducing Allergic Reactions to Multiple Foods

(IN BRIEF) Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) under Priority Review. The sBLA is for the reduction of allergic reactions, including anaphylaxis, caused by … Read the full press release

ONS Reveals Unchanged Suicide Rates in England and Wales for 2022: Calls for Urgent Action

(IN BRIEF) The Office for National Statistics (ONS) has released data on suicides in England and Wales for the year 2022, highlighting the persistence of suicide rates that have remained largely unchanged for over two decades. In response to the … Read the full press release

Almirall S.A. to Participate in 42nd Annual J.P. Morgan Healthcare Conference

(IN BRIEF) Almirall S.A., a global pharmaceutical company specializing in medical dermatology, has confirmed its involvement in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, taking place from January 8th to 11th, 2024. Carlos Gallardo, Chairman and CEO … Read the full press release

TU/e Researchers Achieve Breakthrough in Early Esophageal Cancer Detection Using AI

(IN BRIEF) Researchers at Eindhoven University of Technology (TU/e) have made a significant breakthrough in the early detection of esophageal cancer through the use of artificial intelligence (AI). Over a decade of research led by Fons van der Sommen has … Read the full press release

Interreg Grants €1.2 Million to UT-Led BRIDGE Project for Cross-Border Healthcare Cooperation

(IN BRIEF) The European grant scheme Interreg has awarded over €1.2 million to the University of Twente (UT) research project BRIDGE, which is dedicated to cross-border healthcare cooperation. Scheduled to commence in spring 2024, BRIDGE aims to map ongoing initiatives, … Read the full press release

Breakthrough Discovery: New Proteins Enhance Botox Effectiveness in Medical Treatments

(IN BRIEF) Researchers at PSI have made a surprising discovery that could expand the medical applications of botulinum toxin A1, commonly known as Botox. They have developed antibody-like proteins called DARPins that unexpectedly accelerate the toxin’s impact on nerve signal … Read the full press release

BioNTech Inaugurates mRNA Vaccine Manufacturing Site in Rwanda, Aims to Boost Vaccine Equity in Africa

(IN BRIEF) BioNTech has achieved a significant milestone in expanding mRNA vaccine manufacturing in Africa with the inauguration of its Kigali site, which includes the first manufacturing unit known as BioNTainer. This move is part of BioNTech’s broader efforts to … Read the full press release